Dicronis raises €105K Bridge round
3 July 2017· Zurich, Switzerland· health, diagnostics, biotech, wearable_technology, software_hardware, b2b
The loan will be employed in the bring-to-market of Dicronis's first product, Lymphit.
Investors
LeadVolkswirtschaftstiftung
About Dicronis
Stage
Pre-Seed
Headquarters
Zurich, Switzerland
Founded
2016
Team Size
6–20
Sectors
healthdiagnosticsbiotechwearable_technologysoftware_hardwareb2b
Source: https://www.dicronis.com/news_4